Dr. Carol Kasper: Honoring the Legacy
Brian O Mahony, CEO of Irish Haemophilia Society,former President of WFH and EHC, shared a devastating news on X:
”I was immensely sad today to hear of the passing of Dr. Carol Kasper, a pioneering treater of haemophilia, a great researcher, a wonderful writer (her Hemophilia Bulletin in the 1990s and early 2000s was the best source of information). I had the great pleasure of working closely with Carol from 1994 to 2002 when she was Vice President Medical of The World Federation of Hemophilia and I was President. She was immensely knowledgable, a great teacher and very empatetic. She was great fun to travel with and had a great sense of humour. She added value to many lives.”
We are deeply saddened by the passing of Dr. Carol Kasper, a pioneering figure in hemophilia care and a beloved member of the global bleeding disorders community.
Dr. Kasper was not only a brilliant clinician and researcher but also a gifted communicator—her Hemophilia Bulletin in the 1990s and early 2000s remains one of the most insightful resources of its time.
Her legacy will live on!
Stay updated on the news in hematology field with Hemostasis Today.
-
Oct 17, 2026, 02:00How Antiphospholipid Syndrome Can Affect the Adrenal Glands – APS Foundation of America
-
Oct 17, 2026, 01:59Liza-Marie Johnson: How Far Should Clinicians Go to Influence Parents’ Decisions?
-
Oct 17, 2026, 01:54Jim Hoffman: The Importance of Self-Advocacy and Understanding Autoimmune Mechanisms
-
Oct 17, 2026, 01:53Kristopher Jonas: Listening to Patients and Recognizing the Donors Who Make Treatment Possible
-
Oct 16, 2026, 18:12Adil Nawaz: Extended Dual Antiplatelet Therapy After Coronary Stenting
-
Oct 16, 2026, 17:50Elad Asher։ STORM-PE Shows Functional Benefits of Thrombectomy
-
Oct 16, 2026, 17:32Shruthi Narayan: STORM-PE and STRIKE-PE Studies Advance Understanding of Recovery After Pulmonary Embolism
-
Oct 16, 2026, 17:22Wolfgang Miesbach։ What a Near-Perfect FISH Score Fails to See
-
Oct 16, 2026, 17:06Troels Wienecke: Connecting Myeloproliferative Disease and Ischemic Stroke